Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms

Type A and B Monoamine Oxidase in Age-Related Neurodegenerative Disorders: Their Distinct Roles in Neuronal Death and Survival

(2013) Makoto Naoi et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders

(2012) Makoto Naoi et al.   CURRENT PHARMACEUTICAL DESIGN

Neurotrophins and cell death

(2012) Gabriel Ichim et al.   EXPERIMENTAL CELL RESEARCH

‘‘70th Birthday Professor Riederer’’ Induction of glial cell line-derived and brain-derived neurotrophic factors by rasagiline and (−)deprenyl: a way to a disease-modifying therapy?

(2012) Wakako Maruyama et al.   JOURNAL OF NEURAL TRANSMISSION

Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells

(2012) Keiko Inaba-Hasegawa et al.   JOURNAL OF NEURAL TRANSMISSION

I1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline

(2012) Yaron D. Barac et al.   PLoS One

Topological Probes of Monoamine Oxidases A and B in Rat Liver Mitochondria: Inhibition by TEMPO-Substituted Pargyline Analogues and Inactivation by Proteolysis

(2011) Jin Wang et al.   BIOCHEMISTRY

GDNF and protection of adult central catecholaminergic neurons

(2011) Alberto Pascual et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Type A monoamine oxidase is associated with induction of neuroprotective Bcl-2 by rasagiline, an inhibitor of type B monoamine oxidase

(2011) Keiko Inaba-Hasegawa et al.   JOURNAL OF NEURAL TRANSMISSION

Transcriptional regulation and multiple functions of MAO genes

(2011) Jean C. Shih et al.   JOURNAL OF NEURAL TRANSMISSION

Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway

(2011) Jan Booij et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Valproic Acid Induces Monoamine Oxidase A via Akt/Forkhead Box O1 Activation

(2011) J. B. Wu et al.   MOLECULAR PHARMACOLOGY

Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor

(2011) A.M. Fletcher et al.   NEUROSCIENCE

MAO-inhibitors in Parkinson's Disease

(2011) Peter Riederer et al.   Experimental Neurobiology

Is mPTP the gatekeeper for necrosis, apoptosis, or both?

(2010) Kathleen W. Kinnally et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Age-related protective effect of deprenyl on changes in the levels of diagnostic marker enzymes and antioxidant defense enzymes activities in cerebellar tissue in Wistar rats

(2010) Manju V. Subramanian et al.   CELL STRESS & CHAPERONES

Apoptosis in Parkinson's disease: Is p53 the missing link between genetic and sporadic Parkinsonism?

(2010) Cristine Alves da Costa et al.   CELLULAR SIGNALLING

Parkinson's disease: insights from pathways

(2010) M. R. Cookson et al.   HUMAN MOLECULAR GENETICS

Regulation of the Inner Membrane Mitochondrial Permeability Transition by the Outer Membrane Translocator Protein (Peripheral Benzodiazepine Receptor)

(2010) Justina Šileikytė et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Macrophage-mediated GDNF Delivery Protects Against Dopaminergic Neurodegeneration: A Therapeutic Strategy for Parkinson's Disease

(2010) KC Biju et al.   MOLECULAR THERAPY

Anterograde Axonal Transport of AAV2-GDNF in Rat Basal Ganglia

(2010) Agnieszka Ciesielska et al.   MOLECULAR THERAPY

What Is the Clinical Significance of the Findings from the Delayed-Start Trial of Rasagiline in Parkinson’s Disease?

(2010) Nicola Vanacore   NEUROEPIDEMIOLOGY

Delayed Start, Rapid Solution?

(2010) Amos D. Korczyn et al.   NEUROEPIDEMIOLOGY

Rasagiline, Parkinson neuroprotection, and delayed-start trials: Still no satisfaction?

(2010) J. E. Ahlskog et al.   NEUROLOGY

Repairing the parkinsonian brain with neurotrophic factors

(2010) Liviu Aron et al.   TRENDS IN NEUROSCIENCES

Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps

(2009) Oren A. Levy et al.   APOPTOSIS

A Novel Role for Glyceraldehyde-3-Phosphate Dehydrogenase and Monoamine Oxidase B Cascade in Ethanol-Induced Cellular Damage

(2009) Xiao-Ming Ou et al.   BIOLOGICAL PSYCHIATRY

Direct inhibition of the mitochondrial permeability transition pore: A possible mechanism for better neuroprotective effects of allopregnanolone over progesterone

(2009) Iqbal Sayeed et al.   BRAIN RESEARCH

Antiapoptotic and neurotrophic effects of antidepressants: A review of clinical and experimental studies

(2009) Łukasz R. Drzyzga et al.   BRAIN RESEARCH BULLETIN

Regulation of Brain-Derived Neurotrophic Factor (BDNF) and Cerebral Dopamine Neurotrophic Factor (CDNF) by Anti-Parkinsonian Drug Therapy In Vivo

(2009) Tobias Gyárfás et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Occurrence Risk and Structure of Depression in Parkinson Disease With and Without Dementia: Results From the GEPAD Study

(2009) Oliver Riedel et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Calcium alters monoamine oxidase-A parameters in human cerebellar and rat glial C6 cell extracts: Possible influence by distinct signalling pathways

(2009) Xia Cao et al.   LIFE SCIENCES

Mitochondrial membrane permeabilization in neuronal injury

(2009) Lorenzo Galluzzi et al.   NATURE REVIEWS NEUROSCIENCE

Comparative Neuroprotective Effects of Rasagiline and Aminoindan with Selegiline on Dexamethasone-Induced Brain Cell Apoptosis

(2009) Shawna Tazik et al.   NEUROTOXICITY RESEARCH

Glyceraldehyde-3-Phosphate Dehydrogenase–Monoamine Oxidase B-Mediated Cell Death-Induced by Ethanol is Prevented by Rasagiline and 1-R-Aminoindan

(2009) Xiao-Ming Ou et al.   NEUROTOXICITY RESEARCH

A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease

(2009) C. Warren Olanow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting post-mitochondrial effectors of apoptosis for neuroprotection

(2008) Lorenzo Galluzzi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications

(2008) Srijan Sen et al.   BIOLOGICAL PSYCHIATRY

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

(2008) Filip Simunovic et al.   BRAIN

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

(2008) T. Pan et al.   BRAIN

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments

(2008) Darrick T. Balu et al.   BRAIN RESEARCH

Neuroprotection by rasagiline in thiamine deficient rats

(2008) Sarah Eliash et al.   BRAIN RESEARCH

GDNF therapy for Parkinson’s disease

(2008) Murray Hong et al.   Expert Review of Neurotherapeutics

The molecular neurobiology of depression

(2008) Vaishnav Krishnan et al.   NATURE

Absolute requirement of GDNF for adult catecholaminergic neuron survival

(2008) Alberto Pascual et al.   NATURE NEUROSCIENCE

Chronic Administration of Mood Stabilizers Upregulates BDNF and Bcl-2 Expression Levels in Rat Frontal Cortex

(2008) Yunyoung C. Chang et al.   NEUROCHEMICAL RESEARCH

MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology

(2008) Jyothi K. Mallajosyula et al.   PLoS One

Driving GDNF expression: The green and the red traffic lights

(2008) Ana Saavedra et al.   PROGRESS IN NEUROBIOLOGY

GDNF and GFRα: a versatile molecular complex for developing neurons

(2008) Gustavo Paratcha et al.   TRENDS IN NEUROSCIENCES

Rasagiline is neuroprotective in a transgenic model of multiple system atrophy

(2007) Nadia Stefanova et al.   EXPERIMENTAL NEUROLOGY

Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness

(2006) Moussa B H Youdim et al.   BRITISH JOURNAL OF PHARMACOLOGY